Abstract
We present a case of a patient who presented to the emergency department with symptoms suggestive of a chronic obstructive pulmonary disease (COPD) exacerbation one day after receiving the BNT162b2 COVID-19 booster vaccine. Laboratory studies indicated she was in a state of inflammation, but not infection. Other potential triggers, including cardiac and viral etiologies, were ruled out. To our knowledge, this is the first documented case of a COPD exacerbation following the administration of the BNT162b2 COVID-19 vaccine.
Recommended Citation
Gatenby, William; Dominah, Gifty; Paudel, Amrit; and Saleh, Nahar
(2022)
"A Chronic Obstructive Pulmonary Disease Exacerbation Following the Administration of a COVID 19-Booster Vaccine: A Case Report,"
Journal of Community Hospital Internal Medicine Perspectives: Vol. 12:
Iss.
5, Article 22.
DOI: 10.55729/2000-9666.1107
Available at:
https://scholarlycommons.gbmc.org/jchimp/vol12/iss5/22
